Alnylam Pharmaceuticals reported $554.65M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Amgen AMGN:US $ 14585M 1716M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Arrowhead Research ARWR:US $ 195.43M 28.25M
Avrobio Inc AVRO:US $ 16.95M 4.18M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Moderna Inc MRNA:US 8.84B 399M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NVS:US $ 29633M 527M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Regeneron Pharmaceuticals REGN:US $ 3732.4M 514.6M
Regulus Therapeutics RGLS:US $ 9.97M 0.1M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Takeda 4502:JP Y 1644766M 128410M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
Xencor XNCR:US $ 45.96M 53.97M
YTE INCY:US $ 660.32M 36.44M